HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesScenario AnalysisRegulatoryStrategyInsightsPricing

Workspace

Workspace

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance66% confidence

FDA AP — MULTIPLE VITAMINS INJECTION PEDIATRIC (PHARMACY BULK PACKAGE) (ORIG)

Source: FDA

Why This Matters

Why this matters: sets a safety guidance precedent in the same sub-indication (ophthalmology) as THEA PHARMA; the same agency is already in play for this signal, so precedent weight is higher.

Regulatory Analysis

Application ANDA210456. Sponsor: APOTEX. Submission status: AP. Submission type: ORIG. Review priority: STANDARD. Active ingredients: ASCORBIC ACID, BIOTIN, CHOLECALCIFEROL, CYANOCOBALAMIN, DEXPANTHENOL, FOLIC ACID, NIACINAMIDE, PYRIDOXINE, RIBOFLAVIN, THIAMINE, TOCOPHEROL ACETATE, VITAMIN A, VITAMIN K.

Supporting Context

Therapeutic area
Ophthalmology · Glaucoma
Sub-indication
Ophthalmology

Related signal: FDA Accepts Application for COSOPT PF Supplement by THEA PHARMA

Source

View source document

Related Signal

Open signal — FDA Accepts Application for COSOPT PF Supplement by THEA PHARMA
PrivacyTermsRefund PolicyDisclaimer

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.